5-Methyl-2-oxa-5,8-diazaspiro[3.5]nonane | 1369103-58-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 5-Methyl-2-oxa-5,8-diazaspiro[3.5]nonane
• CAS: 1369103-58-1
• 化学式: C₇H₁₄N₂O
• 分子量: 142.2
• InChiKey: NNRYNNIIXWCPSD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.9
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  24.5
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Carboxamides as ubiquitin-specific protease inhibitors
  申请人：Valo Early Discovery, Inc.

  公开号：US11524966B1

  公开（公告）日：2022-12-13

  The present disclosure relates to modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25, pharmaceutical compositions comprising the inhibitors, and methods of using the inhibitors. The modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25 can be useful in the treatment of cancers, among other ailments.

  本公开涉及选自USP28和USP25的至少一种通路的调节剂（如抑制剂）、包含这些抑制剂的药物组合物以及使用这些抑制剂的方法。选自USP28和USP25的至少一种通路的调节剂（如抑制剂）可用于治疗癌症等疾病。
• PYRAZOLE DERIVATIVES AND USES THEREOF AS INHIBITORS OF DLK
  申请人：F. Hoffmann-La Roche AG

  公开号：EP3083599B1

  公开（公告）日：2020-07-01
• CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
  申请人：Valo Early Discovery, Inc.

  公开号：US20210323975A1

  公开（公告）日：2021-10-21

  The present disclosure relates to modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25, pharmaceutical compositions comprising the inhibitors, and methods of using the inhibitors. The modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25 can be useful in the treatment of cancers, among other ailments.
• [EN] HETEROCYCLES AND USES THEREOF<br/>[FR] HÉTÉROCYCLES ET LEURS UTILISATIONS
  申请人：[en]KUMQUAT BIOSCIENCES INC.

  公开号：WO2022081912A2

  公开（公告）日：2022-04-21

  The present disclosure provides compounds and pharmaceutically acceptable salt thereof, and methods of using the same. The compounds and methods have a range of utilities as therapeutics, diagnostics, and research tools. In particular, the subject compositions and methods are useful for reducing signaling output of oncogenic proteins.
• WO2022271562A1
  申请人：——

  公开号：WO2022271562A1

  公开（公告）日：2022-12-29